In the demanding field of asymmetric catalysis, the purity of starting materials is not just a specification—it's the bedrock of catalytic performance. For R&D managers developing chiral ligands, particularly those based on amino acid scaffolds like D-Threonine, the presence of trace metal impurities can silently sabotage entire campaigns. At NINGBO INNO PHARMCHEM CO.,LTD., we understand that when you're working with sensitive Rhodium or Ruthenium complexes, even parts-per-million levels of contaminants like copper, iron, or lead can poison your catalyst, leading to erratic enantioselectivities and costly batch failures. Our D-Threonine (CAS 632-20-2), a key chiral building block for ligand synthesis, is manufactured under rigorous controls to ensure it meets the exacting standards of catalytic applications, serving as a drop-in replacement that safeguards your process without requiring revalidation of your entire synthetic route.
